Gupta Wealth Management’s Novo Nordisk NVO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q1
$80K Buy
2,944
+90
+3% +$2.41K 0.02% 364
2015
Q4
$83K Buy
2,854
+1,204
+73% +$33.3K 0.02% 351
2015
Q3
$45K Buy
1,650
+426
+35% +$12.1K 0.01% 468
2015
Q2
$34K Sell
1,224
-280
-19% -$7.87K 0.01% 567
2015
Q1
$40K Buy
+1,504
New +$34.6K 0.01% 442

Other funds holding NVO

Gupta Wealth Management's NVO Position: Q1 2016 in Review

Gupta Wealth Management increased its Novo Nordisk (NVO) stake by 3.2% in Q1 2016, buying an estimated $2.41K and bringing the position to 2,944 shares worth $80K. The position accounts for 0.02% of the portfolio, ranked #364.

Gupta Wealth Management first reported a position in NVO in Q1 2015 and has held it in 5 quarters since. The position peaked at $83K in Q4 2015. 536 funds tracked by Wall St. Rank hold NVO as of Q1 2016.

  • Gupta Wealth Management held 2,944 shares of Novo Nordisk worth $80K as of Q1 2016.
  • Gupta Wealth Management bought 90 Novo Nordisk shares in Q1 2016, an estimated $2.41K.
  • Novo Nordisk made up 0.02% of Gupta Wealth Management's portfolio in Q1 2016, its #364 holding.
  • Gupta Wealth Management first reported a position in Novo Nordisk in Q1 2015 and has held it in 5 quarters since.
  • Gupta Wealth Management's Novo Nordisk position peaked at $83K in Q4 2015.
  • 536 funds tracked by Wall St. Rank held Novo Nordisk as of Q1 2016.

Based on Gupta Wealth Management's 13F filing for Q1 2016, filed 16 May 2016.